These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 20306251)

  • 21. AML1/RUNX1 mutations are infrequent, but related to AML-M0, acquired trisomy 21, and leukemic transformation in pediatric hematologic malignancies.
    Taketani T; Taki T; Takita J; Tsuchida M; Hanada R; Hongo T; Kaneko T; Manabe A; Ida K; Hayashi Y
    Genes Chromosomes Cancer; 2003 Sep; 38(1):1-7. PubMed ID: 12874780
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pathobiology of acute myeloid leukemia].
    Christ O; Feuring-Buske M; Hiddemann W; Buske C
    Med Klin (Munich); 2007 Apr; 102(4):290-5. PubMed ID: 17426932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 14q32/miRNA clusters loss of heterozygosity in acute lymphoblastic leukemia is associated with up-regulation of BCL11a.
    Agueli C; Cammarata G; Salemi D; Dagnino L; Nicoletti R; La Rosa M; Messana F; Marfia A; Bica MG; Coniglio ML; Pagano M; Fabbiano F; Santoro A
    Am J Hematol; 2010 Aug; 85(8):575-8. PubMed ID: 20578197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epigenetic aberrations in acute myeloid leukemia: Early key events during leukemogenesis.
    Eriksson A; Lennartsson A; Lehmann S
    Exp Hematol; 2015 Aug; 43(8):609-24. PubMed ID: 26118500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of NOM1, a nucleolar, eIF4A binding protein encoded within the chromosome 7q36 breakpoint region targeted in cases of pediatric acute myeloid leukemia.
    Simmons HM; Ruis BL; Kapoor M; Hudacek AW; Conklin KF
    Gene; 2005 Feb; 347(1):137-45. PubMed ID: 15715967
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The clinical significance of MDR-1 gene expression in the hemopoietic cells of patients with acute leukemias in different phases of the disease].
    Bykova TV; Sominskaia AA; Zaritskiĭ AIu; Stiuf IIu; Medvedeva BV; Anikina NA; Afanas'ev BV
    Ter Arkh; 1998; 70(7):11-4. PubMed ID: 9742628
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular pathways mediating MDS/AML with focus on AML1/RUNX1 point mutations.
    Harada Y; Harada H
    J Cell Physiol; 2009 Jul; 220(1):16-20. PubMed ID: 19334039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N-ras oncogene-induced gene expression in human hematopoietic progenitor cells: upregulation of p16INK4a and p21CIP1/WAF1 correlates with myeloid differentiation.
    Shen S; Passioura T; Symonds G; Dolnikov A
    Exp Hematol; 2007 Jun; 35(6):908-19. PubMed ID: 17533045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo differentiation of mast cells from acute myeloid leukemia blasts carrying a novel activating ligand-independent C-kit mutation.
    Beghini A; Cairoli R; Morra E; Larizza L
    Blood Cells Mol Dis; 1998 Jun; 24(2):262-70. PubMed ID: 9714703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advances in understanding the biology and genetics of acute myelocytic leukemia.
    McKenzie SB
    Clin Lab Sci; 2005; 18(1):28-37. PubMed ID: 15747784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PU.1: a crucial and versatile player in hematopoiesis and leukemia.
    Kastner P; Chan S
    Int J Biochem Cell Biol; 2008; 40(1):22-7. PubMed ID: 17374502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNAs expressed in hematopoietic stem/progenitor cells are deregulated in acute myeloid leukemias.
    Testa U; Pelosi E
    Leuk Lymphoma; 2015 May; 56(5):1466-74. PubMed ID: 25242094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Innate immune signaling in the myelodysplastic syndromes.
    Starczynowski DT; Karsan A
    Hematol Oncol Clin North Am; 2010 Apr; 24(2):343-59. PubMed ID: 20359630
    [TBL] [Abstract][Full Text] [Related]  

  • 34. t(12;13)(q14;q31) leading to HMGA2 upregulation in acute myeloid leukaemia.
    Nyquist KB; Panagopoulos I; Thorsen J; Roberto R; Wik HS; Tierens A; Heim S; Micci F
    Br J Haematol; 2012 Jun; 157(6):769-71. PubMed ID: 22404713
    [No Abstract]   [Full Text] [Related]  

  • 35. MicroRNA: an important regulator in acute myeloid leukemia.
    Wang X; Chen H; Bai J; He A
    Cell Biol Int; 2017 Sep; 41(9):936-945. PubMed ID: 28370893
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of micro-ribonucleic acids in normal hematopoiesis and leukemic T-lymphogenesis.
    Slavov SN; Gimenes Teixeira HL; Rego EM
    Braz J Med Biol Res; 2010 Jul; 43(7):619-26. PubMed ID: 20549139
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Acute myeloid leukemia: molecular pathogenesis and new therapeutic strategies].
    Goyama S
    Rinsho Ketsueki; 2016 Feb; 57(2):118-28. PubMed ID: 26935629
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p53 lesions in leukemic transformation.
    Harutyunyan A; Klampfl T; Cazzola M; Kralovics R
    N Engl J Med; 2011 Feb; 364(5):488-90. PubMed ID: 21288114
    [No Abstract]   [Full Text] [Related]  

  • 39. Functional significance of c-myb expression in normal and leukemic hematopoiesis.
    Calabretta B; Venturelli D; Gewirtz AM
    Cancer Invest; 1993; 11(2):191-7. PubMed ID: 8462020
    [No Abstract]   [Full Text] [Related]  

  • 40. MiR-139-5p is a potent tumor suppressor in adult acute myeloid leukemia.
    Krowiorz K; Ruschmann J; Lai C; Ngom M; Maetzig T; Martins V; Scheffold A; Schneider E; Pochert N; Miller C; Palmqvist L; Staffas A; Mulaw M; Bohl SR; Buske C; Heuser M; Kraus J; O'Neill K; Hansen CL; Petriv OI; Kestler H; Döhner H; Bullinger L; Döhner K; Humphries RK; Rouhi A; Kuchenbauer F
    Blood Cancer J; 2016 Dec; 6(12):e508. PubMed ID: 27935579
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.